| Literature DB >> 33401879 |
Joon Young Kim1, Justin Y Jeon2.
Abstract
Parallel with the current pediatric obesity epidemic, the escalating rates of youthonset type 2 diabetes mellitus (T2DM) have become a major public health burden. Although lifestyle modification can be the first-line prevention for T2DM in youths, there is a lack of evidence to establish optimal specific exercise strategies for obese youths at high risk for T2DM. The purpose of this narrative review is to summarize the potential impact of exercise on 2 key pathophysiological risk factors for T2DM, insulin sensitivity and β-cell function, among obese youths. The studies cited are grouped by use of metabolic tests, i.e., direct and indirect measures of insulin sensitivity and β-cell function. In general, there are an increasing number of studies that demonstrate positive effects of aerobic exercise, resistance exercise, and the 2 combined on insulin sensitivity. However, a lack of evidence exists for the effect of any exercise modality on β-cell functional improvement. We also suggest a future direction for research into exercise medical prevention of youth-onset T2DM. These suggestions focus on the effects of exercise modalities on emerging biomarkers of T2DM risk.Entities:
Keywords: Childhood obesity; Exercise; Inflammation; Insulin resistance; Insulin secretion; Type 2 diabetes; Visceral fat
Year: 2020 PMID: 33401879 PMCID: PMC7788350 DOI: 10.6065/apem.2040140.070
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
List of references by exercise modalities and existence/absence of significant results
| Variable | AE only | RE only | Combination of AE and RE | Lifestyle intervention | Studies that showed significant improvement | Studies that showed no significant change |
|---|---|---|---|---|---|---|
| (23- | (28, 30-34) | ( | (26) | (23-28, 31-34) | (29-31, 34, 53) | |
| HOMA-IR | (27, 36- | (30, 38, 52, 53) | (30, 46-49, 54) | (26, 50, 51, 60) | (26, 27, 36, 37, 39-42, 45-51, 54) | (30, 38, 44, 52, 53, 57, 58, 60) |
| Fasting Insulin | (23-25, 27, 31, 32, 36-44, | (30-34, 38, 52, 53) | (30, 46-49, 54) | (26, 50, 51, 59, 60) | (23, 25-27, 36, 37, 39-44, 46-51, 54) | ( |
| VAT | (25, 29, 31, 32, | (31, 32, 34, 70) | (47-49, 54, 70) | ( | (25, 31, 32, 42, 47-50, 54, 55, 67-69) | (29, 34, 57, 70) |
| Adiponectin | (23, | (34) | (47, 49, 54) | (36, 47, 49, 54) | (23, 34, 40, 57, 58) | |
| leptin | (23, | (34) | (38, 47) | (60) | (38, 40, 43, 47, 60) | (23, 34) |
| Insulinogenic index | ( | (73) | ( | (73) | ||
| Insulin-AUC | (25, 27, 31, 57, 73) | (31, 73) | ( | (25-27, 57, 73) | (31) | |
| DI | (27, 32) | (30, 32, | (30) | (26, 59) | (27) | (26, 30, 32, 33, 53, 59) |
| AIR | (30, 33, 53) | ( | (59) | (30, 33, 53, 59) |
AE, aerobic exercise; RE, resistance exercise; HOMA-IR, homeostatic model assessment for insulin resistance; VAT, visceral adipose tissue; AUC, area under the curve; DI, disposition index; AIR, acute insulin release.
References recommended by authors indicated in bold.